DOSTINEX 0.5 mg, tablet 8 tablets, CIP 3400930224342
Active ingredients: Cabergoline
Commercialized according to BDPMDispensing in France: Prescription only
Tablet8 tablets, CIP 3400930224342orale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- DOSTINEX 0,5 mg, comprimé
- Pharmaceutical form
- comprimé
- Route of administration
- orale
- Presentation description
- 1 flacon(s) polyéthylène haute densité (PEHD) avec fermeture de sécurité enfant de 8 comprimé(s)
- Marketing authorisation holder
- PFIZER HOLDING FRANCE
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 6 Apr 2022
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69671845CIP73022434CIP133400930224342Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CABERGOLINEcomprimé | 0,5 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.